Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2
Year: 2016
Type: article
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Sanofi, SRA International, Regeneron Pharmaceuticals, Valeant Pharmaceuticals International, Aimmune Therapeutics, National Institutes of Health, Genentech, University of North Carolina at Chapel Hill, National Institute of Allergy and Infectious Diseases, Congressionally Directed Medical Research Programs
OpenAlex ID: W2514358983
